» Authors » Manon van Engeland

Manon van Engeland

Explore the profile of Manon van Engeland including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 136
Citations 5505
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Carvalho B, de Klaver W, van Wifferen F, van Lanschot M, van Wetering A, van der Zander Q, et al.
Gastroenterology . 2024 Sep; 168(1):121-135.e16. PMID: 39218164
Background & Aims: Colonoscopy-based surveillance to prevent colorectal cancer (CRC) causes substantial burden for patients and health care. Stool tests may help to reduce surveillance colonoscopies by limiting colonoscopies to...
2.
Massen M, Thijssen M, Rademakers G, Idris M, Wouters K, van der Meer J, et al.
Mod Pathol . 2024 Jul; 37(10):100565. PMID: 39025405
Over the past years, insights in the cancer neuroscience field increased rapidly, and a potential role for neurons in colorectal carcinogenesis has been recognized. However, knowledge on the neuronal distribution,...
3.
Odeh S, Samarska I, Matoso A, Van De Pol J, Baldewijns M, Hulsbergen-van de Kaa C, et al.
Oncol Lett . 2023 Apr; 25(5):174. PMID: 37033104
The aim of the present study was to re-evaluate 457 renal cell carcinoma (RCC) cases from the Netherlands Cohort Study on Diet and Cancer (NLCS), a large population-based cohort, according...
4.
van der Vlugt M, Carvalho B, Fliers J, Montazeri N, Rausch C, Grobbee E, et al.
World J Gastrointest Oncol . 2022 Nov; 14(11):2195-2207. PMID: 36438700
Background: For optimizing fecal immunochemical test (FIT)-based screening programs, reducing the rate of missed colorectal cancers (CRCs) by FIT (FIT-interval CRCs) is an important aspect. Knowledge of the molecular make-up...
5.
Feng Z, Oberije C, van de Wetering A, Koch A, Wouters K, Vaes N, et al.
Clin Transl Gastroenterol . 2022 May; 13(6):e00499. PMID: 35584320
Objectives: To improve colorectal cancer (CRC) survival and lower incidence rates, colonoscopy and/or fecal immunochemical test screening are widely implemented. Although candidate DNA methylation biomarkers have been published to improve...
6.
de Krijger M, Carvalho B, Rausch C, Bolijn A, Delis-van Diemen P, Tijssen M, et al.
Inflamm Bowel Dis . 2022 May; 28(9):1309-1320. PMID: 35554535
Background: Patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) run a 10-fold increased risk of developing colorectal cancer (CRC) compared to patients with IBD only. The aim...
7.
Massen M, Lommen K, Wouters K, Vandersmissen J, Van Criekinge W, Herman J, et al.
Clin Epigenetics . 2022 Apr; 14(1):56. PMID: 35477541
Background: DNA methylation biomarkers for early detection, risk stratification and treatment response in cancer have been of great interest over the past decades. Nevertheless, clinical implementation of these biomarkers is...
8.
Van De Pol J, Ferronika P, Westers H, van Engeland M, Terpstra M, Smits K, et al.
Sci Rep . 2022 Apr; 12(1):6478. PMID: 35444164
In this study, we investigate the influence of the seven genes (VHL, PBRM1, SETD2, BAP1, KDM5C, MTOR and TP53) most frequently mutated in clear cell renal cell cancer (ccRCC) on...
9.
Moonen L, Mangiante L, Leunissen D, Lap L, Gabriel A, Hillen L, et al.
Int J Cancer . 2022 Jan; 150(12):1987-1997. PMID: 35076935
Limited number of tumor types have been examined for Orthopedia Homeobox (OTP) expression. In pulmonary carcinoids, loss of expression is a strong indicator of poor prognosis. Here, we investigated OTP...
10.
Bogie R, le Clercq C, Voorham Q, Cordes M, Sie D, Rausch C, et al.
Br J Cancer . 2021 Dec; 126(6):865-873. PMID: 34912077
Background: Post-colonoscopy colorectal cancers (PCCRCs) pose challenges in clinical practice. PCCRCs occur due to a combination of procedural and biological causes. In a nested case-control study, we compared clinical and...